Experience and Capabilities
We manufacture clinical batches up to 50 Kg of powder or 50 l of liquid for Phase II trials. Batches of this size can also satisfy the needs of small-scale Phase III clinical trials (e.g. for orphan drugs), though it is more common to manufacture these batches at the final manufacturing site after a tech-transfer.
According to the customer’s needs, the product is transferred to one of our own manufacturing sites, or to the customers’ selected site. In all cases, our teams provide everything necessary to ensure a smooth transfer to the new environment.